aldosterone has been researched along with Asymptomatic Conditions in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Primary aldosteronism (PA) may cause myocardial injury." | 1.51 | Speckle-Tracking Echocardiographic Layer-Specific Strain Analysis on Subclinical Left Ventricular Dysfunction in Patients With Primary Aldosteronism. ( Chen, X; Chen, Y; Li, Y; Shao, S; Wang, D; Wang, JG; Xu, JZ; Xu, TY; Zhang, W; Zhu, LM, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamada, T | 1 |
| Fukuoka, H | 1 |
| Hosokawa, Y | 1 |
| Odake, Y | 1 |
| Yoshida, K | 1 |
| Matsumoto, R | 1 |
| Bando, H | 1 |
| Okada, Y | 1 |
| Hirota, Y | 1 |
| Iguchi, G | 1 |
| Ogawa, W | 1 |
| Takahashi, Y | 1 |
| Wang, D | 1 |
| Xu, JZ | 1 |
| Chen, X | 1 |
| Chen, Y | 1 |
| Shao, S | 1 |
| Zhang, W | 1 |
| Zhu, LM | 1 |
| Xu, TY | 1 |
| Li, Y | 1 |
| Wang, JG | 1 |
| Boonen, L | 1 |
| Verbrugge, FH | 1 |
| Nijst, P | 1 |
| Noyens, P | 1 |
| De Vusser, P | 1 |
| Verhaert, D | 1 |
| Van Lierde, J | 1 |
| Vrolix, M | 1 |
| Dupont, M | 1 |
| Mullens, W | 1 |
| Kishino, M | 1 |
| Yoshimoto, T | 1 |
| Nakadate, M | 1 |
| Katada, Y | 1 |
| Kanda, E | 1 |
| Nakaminato, S | 1 |
| Saida, Y | 1 |
| Ogawa, Y | 1 |
| Tateishi, U | 1 |
| Cao, CX | 1 |
| Yang, XC | 1 |
| Gao, YX | 1 |
| Zhuang, M | 1 |
| Wang, KP | 1 |
| Sun, LJ | 1 |
| Wang, XS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Diuretic Efficiency in Patients With Stable Heart Failure: Ion Excretion Capacity of the Kidneys (DIPSTICK) Study[NCT02288819] | 50 participants (Actual) | Interventional | 2014-09-30 | Terminated (stopped due to Slow recruitment and a lack of funding to complete further follow-up) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT02288819)
Timeframe: 30 days after baseline
| Intervention | Participants (Count of Participants) |
|---|---|
| Loop Diuretic Downtitration | 1 |
"NYHA class is a semi-quantitative measurement of functional capacity on a scale from 1 to 4:~No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea (shortness of breath).~Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases.~For the purpose of this outcome parameter, the patient is contacted by phone 30 days after baseline and NYHA functional class is assessed by a study investigator." (NCT02288819)
Timeframe: 30 days after baseline
| Intervention | units on a scale from 1 to 4 (Mean) |
|---|---|
| Loop Diuretic Downtitration | 1.41 |
Unplanned hospital admission for symptoms of congestion and/or low output heart failure requiring either intravenous therapy and/or increase of oral diuretics. (NCT02288819)
Timeframe: 30 days after baseline
| Intervention | Participants (Count of Participants) |
|---|---|
| Loop Diuretic Downtitration | 1 |
Dose increase of oral maintenance therapy with loop diuretics compared to the final dose achieved in the study 7 days after baseline. (NCT02288819)
Timeframe: 30 days after baseline
| Intervention | Participants (Count of Participants) |
|---|---|
| Loop Diuretic Downtitration | 1 |
After baseline evaluation, loop diuretics are temporarily downtitrated or stopped for 7 consecutive days. The patient is instructed to measure his/her weight in the morning of these days, immediately after waking up, on the same balance. In case of weight increase >1,5 kg, the original dose of diuretics is restored. To check this, patients are contacted by phone after 3 and 7 days. If the patient has not gained >1,5 kg of weight after 7 days, loop diuretics are considered to be successfully downtitrated. (NCT02288819)
Timeframe: 7 days after baseline
| Intervention | Participants (Count of Participants) |
|---|---|
| Loop Diuretic Downtitration | 37 |
The patient is contacted by phone 30 days after baseline and asked for self-reported presence of lower leg edema. (NCT02288819)
Timeframe: 30 days after baseline
| Intervention | Participants (Count of Participants) |
|---|---|
| Loop Diuretic Downtitration | 1 |
The patient is contacted by phone 30 days after baseline and asked for self-reported orthopnea. (NCT02288819)
Timeframe: 30 days after baseline
| Intervention | Participants (Count of Participants) |
|---|---|
| Loop Diuretic Downtitration | 5 |
Weight change [kg] 30 days after baseline compared to weight 7 days after baseline (after achieving the final dose of loop diuretics). (NCT02288819)
Timeframe: 30 days after baseline
| Intervention | kg (Mean) |
|---|---|
| Loop Diuretic Downtitration | -0.261 |
Weight change [kg] 7 days after baseline compared to baseline weight. (NCT02288819)
Timeframe: 7 days after baseline
| Intervention | kg (Mean) |
|---|---|
| Loop Diuretic Downtitration | 0.502 |
5 other studies available for aldosterone and Asymptomatic Conditions
| Article | Year |
|---|---|
Patients with pheochromocytoma exhibit low aldosterone renin ratio-preliminary reports.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Aldosterone; Asymptomatic Diseases; Cross-Sectional Studies; C | 2020 |
Speckle-Tracking Echocardiographic Layer-Specific Strain Analysis on Subclinical Left Ventricular Dysfunction in Patients With Primary Aldosteronism.
Topics: Adult; Aged; Aldosterone; Asymptomatic Diseases; Biomarkers; Blood Pressure; Case-Control Studies; C | 2019 |
Subclinical volume overload in stable outpatients with chronic heart failure.
Topics: Aged; Aged, 80 and over; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Asymptomatic Disease | 2016 |
Optimization of left adrenal vein sampling in primary aldosteronism: Coping with asymmetrical cortisol secretion.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Asymptomatic Diseases | 2017 |
Expression of aldosterone synthase and adrenocorticotropic hormone receptor in adrenal incidentalomas from normotensive and hypertensive patients: Distinguishing subclinical or atypical primary aldosteronism from adrenal incidental
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Asymptomatic Diseases; Biomark | 2012 |